A collaborative research effort led by scientists at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School…
Read More
Scientists Recreate Human Bone Marrow in Laboratory Breakthrough for Cancer Research and Drug Development
The human body’s hematopoietic system, often referred to as the "blood factory," is one of the most complex and dynamic…
Read More
Genetic Mutations Shared by Cancer and Blood Cells Identified as Potential Drivers of Alzheimer’s Disease Pathogenesis
Recent breakthroughs in genomic sequencing have fundamentally altered our understanding of how the human body ages, revealing that the genetic…
Read More
Radiopharmaceuticals Ascend: ASCO 2026 Highlights Evolving Cancer Treatment Landscape
The burgeoning field of radiopharmaceuticals, propelled by the success of treatments like Novartis’s Pluvicto (lutetium Lu 177 vipivotide tetraxetan), is…
Read More
Bioengineered Bone Marrow Platform Offers New Frontier for Cancer Treatment Drug Testing and Deep Space Exploration
Researchers at the University of Pennsylvania School of Engineering and Applied Science, the Perelman School of Medicine, and the Children’s…
Read More
Unraveling the Mysteries of Whole Genome Duplication: How Cell Division Errors Shape Cellular Fate and Cancer Progression
Every second, in the intricate theater of the human body, countless cells undergo a fundamental act of creation: division. This…
Read More
Beyond PD-1: The Drugs Reshaping Cancer Treatment at ASCO 2026
The biomedical sector is once again experiencing a vibrant resurgence, marked by robust investment, strategic mergers and acquisitions (M&A), and…
Read More
Ludwig Cancer Research Study Identifies Novel Synergistic Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia
The landscape of hematological oncology faces a persistent and formidable challenge in the form of acute myelogenous leukemia (AML), a…
Read More
FDA Approves a Wave of Oncology Innovations: New Therapies, Diagnostics, and Imaging Agents Usher in a New Era of Cancer Care
The US Food and Drug Administration (FDA) has recently authorized a series of significant advancements in oncology, encompassing novel therapeutic…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Driving Rare Translocation Kidney Cancer Through Liquid Condensate Formation
In a significant advancement for the field of oncology, investigators at the Johns Hopkins Kimmel Cancer Center and the Johns…
Read More
